5566.0000 -31.00 (-0.55%)
NSE Dec 24, 2025 15:52 PM
Volume: 41,257
 

5566.00
-0.55%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended